Statistics
Publications
2
Citations
284
H-Index
2
Active since
2005
Affiliations
Mike Fennell is an author at AstraZeneca (United Kingdom) specializing in tyrosine kinase inhibitors, medicine, and src family kinase inhibitors.
Publications per year
2005–2009
2
2
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 256 citations · Full text
Medicine, Oncology, Pharmacology +10
1–2 of 2